en
Scientific article
English

Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study

Published inLancet oncology, vol. 15, no. 9, p. 931-942
Publication date2014
Abstract

More effective treatments have become available for haematological malignancies from the early 2000s, but few large-scale population-based studies have investigated their effect on survival. Using EUROCARE data, and HAEMACARE morphological groupings, we aimed to estimate time trends in population-based survival for 11 lymphoid and myeloid malignancies in 20 European countries, by region and age.

Keywords
  • Adolescent
  • Adult
  • Aged
  • Cause of Death
  • Cohort Studies
  • Combined Modality Therapy
  • Confidence Intervals
  • Disease-Free Survival
  • Europe
  • Female
  • Hematologic Neoplasms/diagnosis/mortality/therapy
  • Humans
  • Male
  • Middle Aged
  • Registries
  • Retrospective Studies
  • Risk Assessment
  • Severity of Illness Index
  • Survival Analysis
  • Young Adult
Citation (ISO format)
SANT, Milena et al. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. In: Lancet oncology, 2014, vol. 15, n° 9, p. 931–942. doi: 10.1016/S1470-2045(14)70282-7
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1470-2045
654views
1downloads

Technical informations

Creation12/16/2014 1:20:00 PM
First validation12/16/2014 1:20:00 PM
Update time03/14/2023 10:36:24 PM
Status update03/14/2023 10:36:23 PM
Last indexation01/16/2024 3:37:57 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack